You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
44 Body composition may be prognostic and predictive of clinical outcomes in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202069010
Dec 20202005
Jan 20211200
Feb 20214407
Mar 20213704
Apr 20212405
May 2021104
Jun 2021004
Jul 20210011
Aug 2021004
Sep 2021001
Oct 20213203
Nov 20211405
Dec 2021400
Jan 20222403
Feb 20221401
Mar 20221601
Apr 20226003
May 20222605
Jun 20222202
Jul 20221601
Aug 2022703
Sep 2022801
Oct 20221000
Nov 2022801
Dec 20221800
Jan 20231400
Feb 20231600
Mar 20231200
Apr 2023203
May 2023600
Jun 2023800
Jul 20232003
Aug 2023400
Sep 20231000
Oct 20231204
Nov 20232002
Dec 20233200
Jan 20241400
Feb 2024600
Mar 20242001
Apr 20241400
May 2024801
Jun 20241800
Jul 2024800
Aug 20241002
Sep 20241402
Oct 2024804
Nov 20241002
Dec 20241405
Jan 2025604
Feb 2025007
Mar 2025008
Apr 2025004
May 2025004
Jun 2025003
Total7920143